Lake Forest, Ill.-based Hospira said Tuesday that it will pay $400 million to acquire a portfolio of injectable drugs from a large Indian drugmaker.
Hospira to buy drug portfolio from India's Orchid Chemicals
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.